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1. Introduction 
Recent improvements in the determination of
acetaldehyde (AcH) in biological samples [l-3] have 
generated an increasing number of investigations into 
in vivo AcH metabolism, which may be of importance 
in the toxic actions of ethanol. AcH is a reactive 
compound and it has been proposed that it can readily 
bind to sulphydryl groups [4-61. Nevertheless, despite 
many speculations, it has not been conclusively shown 
that AcH actually exists in a bound form in blood 
in vivo. 
In previous experiments [3] using head-space 
chromatography we found that the recovery of AcH 
added to rat blood decreased with the time between 
the AcH addition and the precipitation of protein 
with perchloric acid (PCA). No decrease of the AcH 
recovery was found, however, if the blood samples 
were hemolysed with water, instead of being treated 
with PCA. This implied that binding of AcH occurred 
in the blood and that some of the bound AcH had 
been lost with the proteins when these were removed 
during the PCA procedure. We now report our exa- 
mination of this binding phenomenon. 
AcH was found to be unevenly distributed in rat 
blood during ethanol oxidation because of binding 
in the erythrocytes. The calculated in vivo free AcH 
concentration i the plasma was about 40% of the 
whole blood AcH concentration. The capacity of the 
rat blood to bind AcH in vitro correlated positively 
with the blood hemoglobin concentration. The cal- 
culated maximum binding capacity of 1 molecule of 
hemoglobin was 4 molecules of AcH. In contrast no 
significant binding of AcH was found in human blood. 
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2. Materials and methods 
In the in vivo part of the investigations different 
doses of ethanol (0.75 g/kg, 1.5 g/kg or 3.0 g/kg) 
were given intraperitoneally as a 15% (v/v) solution 
in saline to fed rats of both sexes of different rat 
strains (Wistar, Sprague-Dawley or Long-Evans). These 
ethanol doses gave AcH levels between 20 PM and 
300 PM in the whole heparinized blood of the rats 
decapitated 15-40 min after the ethanol administra- 
tion. The AcH concentrations were determined by 
head-space hromatography directly from the whole 
blood samples diluted with water, as previously 
described [3]. Part of the blood was kept on ice for 
up to 40 min and at intervals, plasma samples were 
obtained by 2 min centrifugation of the whole blood 
at 24’C and 1500 X g. The plasma nd the remaining 
erythrocyte fraction AcH was measured in the same 
way as for the whole blood samples. Control experi- 
ments were performed in vitro, in which the total 
blood of decapitated fed rats of both sexes was added 
to AcH and ethanol in saline (containing heparin) to 
give the same initial whole blood AcH and ethanol 
concentrations (in about 100 parts blood and 1 part 
saline) as those in the in vivo experiments. 
Male and female human blood was obtained from 
antecubital veins. The treatment of the blood was, 
however, complicated by the fact that hemolysed 
human blood in the presence of ethanol causes a
strong non-enzymatic AcH formation. Also the 
normal procedure of ice-cold PCA precipitation 
followed by centrifugation results, at least in rats, in 
a loss of some of the bound AcH [3]. In preliminary 
experiments we found that the recovery of rat blood 
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AcH increased if the temperature of the precipitating 
PCA was raised, apparently because of a more 
complete liberation of the bound AcH. At 25°C 
practically all the bound AcH was released. 
Thus in the human blood studies, which were similar 
in design to the rat experiments in vitro, we precipitat- 
ed the blood, plasma and cell samples with 25°C PCA. 
The AcH was determined from the supernatants as 
described previously [3]. 
The AcH binding capacity of the rat blood was 
investigated by the addition of increasing AcH con- 
centrations to rat blood from fed male and female 
Sprague-Dawley animals to final total AcH concentra- 
tions of 3- 16 mM. Plasma was separated by centri- 
fugation after 40 min incubation at 4°C and the AcH 
was measured from the whole blood, plasma and 
erythrocyte fraction diluted with water, as described 
previously [3] . The concentration of bound AcH in 
whole blood, i.e., [AcH],~~~ bk,od - [AcHJfree, 
divided by the free AcH concentration, was plotted 
against the concentration of bound AcH in whole 
blood. The concentration of free AcH in whole blood 
was taken to be 0.88 [AcH] lasma. This coefficient 
came from the calculation o F the total amount of free 
AcH per volume of blood, considering the difference 
in the water volumes of the plasma and erythrocyte 
fraction. According to Scatchard [7], the intercept 
on the [AcHlbound axis estimates the theoretical 
maximum amount of bound AcH in whole blood. 
In the last part of the investigations the ferric 
citrate (the only source of iron) was withdrawn from 
the salt mixture of the diet used for the rats (male 
Sprague-Dawley), in order to produce a gradual 
decrease of the blood hemoglobin concentration 
within 2 weeks. The blood hemoglobin concentrations 
were measured using the methods described by 
Hainline [8,9] . 
3. Results and discussion 
3.1. Occurrence of acetaldehyde binding 
The various AcH levels (20-300 PM) in the whole 
blood obtained in the in vivo part of the experiments 
were found to be steady during the first 40 min at 
4’C after decapitation. The AcH concentration in the 
separated plasma, however, decreased with the time 
between decapitation and centrifugation (curve A in 
II 1 I I 
35 10 20 LO 
Time i min) 
Fig.1. Relation between plasma and whole blood acetaldehyde 
concentration as a function of time. The time scale expresses 
the times before removing the plasma and (A) the decapita- 
tion of rats to which different ethanol doses had been given 
in vivo and (B) the in vitro addition of acetaldehyde and 
ethanol to blood of decapitated rats. For details see 
Materials and methods section. The values are the means of 
14-15 rats (SD = S-20%). The dotted Line is the extra- 
polation of curve A to zero time. 
tig.1). The decrease was independent of sex, strain, 
the initial AcH concentration produced by the dif- 
ferent ethanol doses and the duration of the ethanol 
oxidation (the data points in fig.1 are means of the 
pooled values). The decreased plasma AcH concen- 
trations with time were also found to be matched by 
simultaneous increases in the AcH concentrations of 
the corresponding erythrocyte fractions. This indicated 
that the decrease of the plasma AcH was not due to 
any physical losses during the treatment but rather 
to binding in the erythrocyte fraction. The extra- 
polated time function of curve A in fig.1 gave a 
plasma AcH concentration of only 40% of the corre- 
sponding whole blood AcH concentration at zero 
time, i.e., the time of decapitation. 
Curve B of fig. 1 shows the results of the experi- 
ment performed in vitro in order to control the 
consistency of the in vivo binding of AcH. Within 
20 min the binding effect reached the same equili- 
brium state as in the in vivo studies, with the plasma 
AcH concentration being only 20% of the whole 
blood AcH concentration. A comparison of the 
curves obtained from the in vivo (A) and in vitro (B) 
experiments confirmed that the AcH in vivo (at the 
time of decapitation) was partly bound in the rat 
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blood. This follows since, if the shape of curve A 
would have only been the result of some very fast 
initial reaction instead of partial binding at time zero, 
the same reaction should have appeared in curve B. 
An advantage with rat blood is that water-diluted 
blood, plasma or cell samples can be used directly 
for the head-space analyses and any bound AcH is 
liberated uring the preheating prior to the analyses. 
With human blood the situation is more complex, 
because of the strong non-enzymatic AcH formation 
occurring in hemolysed human blood in the 
presence of ethanol [3]. This was not considered in 
two earlier studies [lo,1 1 ] , which probably resulted 
in erroneous conclusions about the binding of AcH 
in human blood. The present method using PCA 
precipitation also causes aslight non-enzymatic AcH 
formation dependent on the ethanol concentration 
[3]. Because ethanol was present in our samples, we 
obtained artificially higher AcH levels in whole blood 
and the erythrocyte fraction than in the correspond- 
ing plasma. The result was a steady [AcH] lasma X
’ “1 LAcH] whole blood ratio of 75, which a F ter correc- 
tion for the ‘spontaneous’ formation became approxi- 
mately 100. The time-dependent decrease in the 
plasma AcH concentration, caused by binding in the 
erythrocytes that was seen with the rat blood, could 
not be demonstrated with the human blood. 
3.2. Characterization of the acetaldehyde binding 
A Scatchard plot gave an estimated maximum 
binding capacity of 8.19 i: 0.92 pmol AcH/ml blood 
(mean f SD, n = 18) for the rats. This extremely 
high capacity of the rat blood to bind AcH made us 
focus attention on the possible role of the hemo- 
globin in the binding effect. Accordingly, we with- 
drew the ferric citrate from the food given to the 
rats. This caused a gradual decrease of the blood 
hemoglobin concentration (from about 2.3-l .8 mM 
within 2 weeks) and a simultaneous decrease in the 
maximum capacity of the blood to bind AcH (fig.2). 
The significance (p < 0.05) of the correlation 
presented in fig.2 strongly supports the view that the 
blood hemoglobin is the protein responsible for the 
binding of the AcH. The molar ratio of the theoretical 
maximum concentration of bound AcH and the 
hemoglobin concentration was 4.06 f 0.38, showing 
that each molecule of hemoglobin can bind at most 
4 molecules of AcH. It is probably of significance 
Hemoglobin concentration 1 ~moleIml blood 1 
Fig.2. Correlation between the estimated theoretical maximum 
capacity of acetaldehyde binding and the hemoglobin con- 
centration in rat blood. For details see Materials and methods 
section. 
that native rat hemoglobin has 4 reactive sulphydryl 
groups/molecule [ 121. Why the human blood, con- 
taining 2 reactive sulphydryl/hemoglobin molecule 
[12], did not bind any acetaldehyde could not be 
explained. 
The physiological consequences of the AcH binding 
in rat blood might be important. The effect could, 
for example, partly explain why the brain AcH con- 
centrations during ethanol oxidation in rats do not rise 
until very high arterial blood AcH concentrations are 
reached [ 13,141. The demonstration of one type of 
AcH binding in rat blood raises the important possi- 
bility that other AcH bindings with potent pharma- 
cological effects might occur in the brain or other 
tissues during and after the ethanol metabolism 
in vivo. 
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